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Most Forkhead box P3+ (Foxp3+) CD4 regulatory T cell (Treg) pre-
cursors are newly formed thymocytes that acquire Foxp3 expression
on antigen encounter in the thymus. Differentiation of Treg, how-
ever, can also occur in the periphery.What limits this second layer of
self- and nonself-reactive Treg production in physiological condi-
tions remains to be understood. In this work, we tested the hypoth-
esis that, similarly to thymic Treg, the precursors of peripheral Treg
are immature T cells. We show that CD4+CD8−Foxp3− thymocytes
and recent thymic emigrants (RTEs), contrarily to peripheral naïve
mature cells, efficiently differentiate into Treg on transfer into lym-
phopenic mice. By varying donor and recipient mice and conducting
ex vivo assays, we document that the preferential conversion of
newly formed T cells does not require intrathymic preactivation, is
cell-intrinsic, and correlates with low and high sensitivity to natural
inhibitors and inducers of Foxp3 expression, such as IL-6, T-cell re-
ceptor triggering, and TGF-β. Finally, ex vivo analysis of human thy-
mocytes and peripheral blood T cells revealed that human RTE and
newly developed T cells share an increased potential to acquire
a FOXP3brightCD25high Treg phenotype. Our findings indicating that
RTEs are the precursors of Tregs differentiated in the periphery
should guide the design of Treg-based therapies.
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Forkhead box P3 (Foxp3) -expressing CD4 regulatory T cells(Tregs) are antigen-specific suppressor cells that prevent au-
toimmunity and allergy, dampen protective responses, and restrict
associated immunopathologies (1). Although never directly
shown, it is predicted that tight regulation of Treg production and
expansion is required to prevent immune paralysis while ensuring
tolerance to tissue antigens. Treg were first shown to differentiate
in the thymus from newly developed thymocytes on T-cell re-
ceptor (TCR) engagement by antigen expressed and/or presented
locally (2). Time and space constraints defined by intrathymic
development would suffice to explain the restricted domain of
specificity and physiological competence of Treg reaching the
periphery. Hence, the thymic Treg (tTreg) reactive repertoire is
necessarily restricted to self-antigens, including peripheral tissue-
specific gene products expressed promiscuously by thymic epi-
thelial cells (3), and peripheral antigens accessing the thymus
(4, 5). It is now well-documented, however, that Treg can also
differentiate in the periphery (pTreg) in both therapeutic and
physiologic settings. Antigen-specific pTregs were reported on s.c.
administration of peptides (6) or exposure to intestinal food (7) or
microbiota (8) antigens. Peripheral de novo differentiation of
Treg was also documented during pregnancy (9) and in conditions
of lymphopenia (10). Hence, pTreg differentiation may com-
plement tTreg self-reactive repertoire by including reactivities
against those self-antigens not expressed in the thymus, but it may
also recruit clones that are reactive to fully foreign antigens. It
follows that the mechanisms limiting extrathymic Treg differenti-
ation in physiological conditions are essential to ensure tolerance
while maintaining protective immune responses. Such mechanisms
remain to be elucidated, and it can be anticipated that interfering
with these processes would help to improve the development of
therapies that aim at enhancing or inhibiting de novo Treg dif-
ferentiation, such as in autoimmune diseases and transplantation
or cancer, respectively.
In the last few years, several studies have addressed differ-
ences between tTreg and pTreg both phenotypically and func-
tionally as well as concerning the signals required for their
differentiation. This body of work, however, does not provide
a consensual picture. Thus, expression of various membrane and
nuclear molecules tentatively subdivided tTreg and pTreg in
some but not other experimental settings (8, 11, 12). Epigenetic
marks, notably CG methylation at the Foxp3 regulatory
sequences, were shown to dissociate tTreg from in vitro-induced
Treg (iTreg) but not pTreg (13). Controversies also arose as to
whether TGF-β is required for Foxp3 induction solely in pe-
ripheral cells, notably through engagement of the smad3 motif in
the CNS1 regulatory sequence 5′ of the coding region (14–17).
Overall, tTreg and pTreg share many features, among which is
a similar two-step process for their differentiation from TCR to
IL-2 signaling (18–20). Because these signals are abundant in the
periphery, physiological limitation of pTreg production should
rely on other features.
In this work we hypothesized that the precursors of pTreg are
limiting and similarly to tTreg, that they are recently developed
T cells. Adoptive transfer experiments in lymphopenic mice in-
dicated that thymocytes as well as recent thymic emigrants (RTEs)
readily acquire a Treg phenotype in the periphery. In contrast, very
few peripheral mature resident naïve cells, if purged of RTEs by
either thymectomy or cell sorting, ever converted to Foxp3+ Treg
in this assay. T-cell maturation stage also conditioned in vitro-
induced Foxp3 expression in both mice and humans. The de-
creased susceptibility of mature cells to acquire a Treg phenotype
was further correlated with their increased sensitivity to inhibitors,
such as IL-6, and decreased sensitivity to facilitators, such as TGF-
β. Together, our results show that T-cell maturation stage con-
ditions de novo Foxp3 expression and that RTEs are the prefer-
ential or exclusive precursors of Tregs differentiated in the
periphery. These findings provide a rationale for limited pTreg in
physiology and raise specific concerns for the success of pTreg-
based therapies in all situations of limited thymopoiesis.
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Results
Newly Developed CD4 T Cells Are Enriched in Precursors of Tregs. To
directly test whether maturation stage correlates with CD4 T-cell
ability to acquire Foxp3 expression in vivo, we first compared newly
formed single-positive (SP) CD4 thymocytes with peripheral CD4
cells isolated from lymph nodes (LNs) in assays of lymphopenia-
induced Treg differentiation (8). The two cell subsets were isolated
from Foxp3-gfp reporter mice (21), purified as GFP−, and sepa-
rately injected i.v. into T cell-deficient animals (TCRβ−/−). Because
donor and recipient mice were raised in strict specific pathogen
free conditions, adoptive transfer did not result in noticeable pa-
thology for at least 8 wk. Cellular analysis was performed at 4 wk
posttransfer, and donor cells were identified as CD4+ TCRβ+ (Fig.
1). As described earlier (8), a small but readily detectable fraction
of LN cells acquired Foxp3 expression, never exceeding 2.5%of the
recovered cells. Strikingly, this frequency was 4- to 10-fold higher in
recipients of CD4 SP thymocytes in all lymphoid organs analyzed,
including those LNs draining the intestine (Fig. 1 A and B). Skin-
draining LNs, such as brachial, inguinal, and axillary, analyzed ei-
ther pooled or separately appeared as preferential sites for Foxp3+
cell differentiation and/or accumulation. Importantly, thymocytes
expanded less than CD4 LN cells in these organs but equally well in
other sites (Fig. 1C); however, thymocytes invariably gave rise to
more Foxp3+ cells than LN cells (Fig. S1A shows the summary of
six independent experiments). We ascertained that our results did
not owe to trivial cell-sorting artifacts by performing voluntary
contamination experiments (Fig. S1B). We also tested and evi-
denced that resident lymphocytes in WT recipient mice rendered
mildly lymphopenic the day before injection do not interfere with
the preferential capacity of thymocytes to acquire Foxp3 expression
(Fig. S1C). Together, these results establish that thymocytes are
selectively prone to undergo true de novo differentiation into
a Foxp3+ phenotype after reaching the periphery.
Peripheral Tregs Derived from Thymocytes and LN Cells Are
Functionally and Phenotypically Indistinguishable. Several surface
markers have been proposed to discriminate Tregs that were
generated in the thymus or induced in the periphery. We tested
whether Foxp3+ cells originated from thymocytes or LN cells in
the experiments above either differ or share phenotypes. Thymic
and peripheral cells from unmanipulated WT mice served as
references. An additional control consisted of in vivo expanded
Tregs obtained from TCRβ−/− mice that had received a mixture
of Thy1.2 Foxp3+ and Thy1.1 Foxp3− cells isolated from LNs of
unmanipulated WT mice 4 wk earlier. Pairwise analysis of the
surface markers CD103 and killer cell lectin-like receptor
subfamily G member 1 (KLRG1) or glucocorticoid-induced
TNFR family related gene (GITR) and CD25 revealed no
differences between Foxp3+ cells that differentiated from either
LN cells or thymocytes in conditions of lymphopenia (Fig. S2).
These two populations shared a phenotype resembling the pre-
viously described induced Treg [that is, both were enriched in
CD103+KLRG1+ (11) and GITR+CD25+ (12) cells], thus clearly
distinguishable from tTreg and pTreg at steady state but strik-
ingly similar to in vivo expanded Treg. Analysis of Helios and
Nrp1 expression also did not discriminate LN- or thymocyte-
derived Treg in our adoptive transfers (Fig. 2 A and B). How-
ever, both cell subsets displayed a phenotype similar to thymic
Treg, namely Helios+, with a clear Nrp1− subpopulation (12)
that was only residual in Tregs found in the periphery, whether at
steady state or expanded in vivo. Finally, a classical proliferation
assay confirmed that both thymocyte- and LN-derived Foxp3+
cells are suppressors (Fig. 2C). Together, these analyses indicate
that Foxp3+ cells developed from thymocyte or LN cells in
lymphopenic hosts are remarkably similar to bona fide Treg.
Enhanced Susceptibility of Thymocytes to Differentiate into Treg Is
a Cell-Intrinsic Property. We next tested whether the differential
capacity of thymocyte and peripheral cells to acquire Foxp3 ex-
pression was controlled by environmental factors. We first
addressed whether Treg differentiation relied on donor cell
recirculation to the thymus, a process for which thymocytes might
Fig. 1. Thymocytes are enriched in precursors of Tregs that differentiate in the
periphery on lymphopenia. TCRβ−/− mice received i.v. 3 × 105 CD4+CD8−Foxp3−
cells purified fromeither thymi (THY; black symbols) or pooled lymphnodes (LNs;
white symbols) isolated from Foxp3-gfp reporter mice and analyzed 4 wk later
by FACS. (A) Foxp3 expression in gated CD4+TCR+ lymphocytes from the in-
dicated organs in recipient mice. (B and C) Frequency of Foxp3+ cells within
CD4+TCR+ lymphocytes (B) and number of CD4+TCR+ cells (C) recovered in one
experiment (representative of seven repeats) (Fig. S1). Each dot represents one
mouse. biaLN, pooled branchial, inguinal, and axillary LN; LIL, large intestine
lamina propria and intraepithelial lymphocytes; mLN, pooledmesenteric LN; PP,
pooledpayer patches; spl, spleen.Note thedifferent scales in Left andRight. *P<
0.05; **P < 0.01, Mann–Whitney test. LIL data in B: P value of 0.0059, t test.
Fig. 2. Thymocytes and LN cells converted into Treg on lymphopenia are
functionally and phenotypically indistinguishable. (A and B) FACS analysis
for Helios and Nrp1 expression in gated Foxp3+CD4+TCR+ cells (pTreg) from
the spleens of animals treated as in Fig. 1A (A) and distribution of each cell
subset (B). Three populations of Foxp3+ natural Tregs (nTregs) served as
control: thymic (THY) and peripheral (LN) cells from unmanipulated mice
(steady state) and Thy1.2 peripheral cells from TCRβ−/−–recipient mice that
received a mixture of Thy1.1 Foxp3− and Thy1.2 Foxp3+ LN cells at a 9:1 ratio
(nTregLN; posttransfer) 4 wk earlier. (C) Standard suppression assay. Naïve
Foxp3− cells (R) were mixed at a 2:1 ratio with either LN nTreg or pTreg
differentiated in vivo as in Fig. 1.









be more competent. Transfer of thymocytes or LN cells into
athymic nude Foxn1−/− animals reproduced the results obtained
in TCRβ−/− recipients, excluding a contribution of the thymus
(Fig. 3A). Secretion of proinflammatory cytokines by activated
T cells has been proposed to limit naïve T-cell conversion into
Treg in other systems (22). It was conceivable that LN prepara-
tions, enriched in naturally activated cells compared with thy-
mocytes, would produce more of these inhibitory factors on
lymphopenia-induced proliferation. However, adoptive transfers
of peripheral CD4+Foxp3− cells, either unfractionated or purged of
activated cells (CD45RBhi), resulted in similar low frequencies of
Foxp3+ cells (Fig. 3B and Fig. S3A). Moreover, in mice recipient
of both thymocytes and LN cells, each prepared from Thy1 con-
genic donors and mixed at a 1:1 ratio, thymocytes again gave rise
to 5- to 10-fold higher frequency of Treg compared with LN cells
(Fig. 3C). These results exclude specific modifications of en-
vironmental factors on lymphopenia as an explanation for thy-
mocyte and peripheral cell differential conversion to Treg.
Because the thymus is the site of natural Treg differentiation, it
was plausible that our thymocyte preparations were enriched in
precommitted Foxp3− Treg. Expression of CD25 by Foxp3− cells
has been proposed to indicate an early step along the Treg dif-
ferentiation pathway resulting from TCR triggering (18–20).
Depleting CD25+ cells from thymocyte and LN cell preparations
before adoptive transfer (Fig. S3B) did not modify the frequency
of recovered Treg from either donor population (Fig. 3D). In-
cidentally, these latter experiments provided the experimental
design to exclude that our findings would be because of the fusion
Foxp3-gfp allele, recently shown to be an occasional hypomorph,
of potentially unstable expression (23, 24). Exclusion of Foxp3+
cells from WT lymphocytes by selecting CD45RBhighCD25− LN
cells and CD25− thymocytes before adoptive transfer fully
reproduced the differential phenotype (Fig. S3C). To further
exclude antigen-triggered precommitted Treg in our thymocyte
preparations, we performed adoptive transfer of monoclonal
TCR transgenic cells specific for the foreign antigen ovalbumin
(OVA) never exposed to their nominal antigen. Recipient TCRβ−/−
mice were injected i.v. with either PBS or endotoxin free OVA
the day before and 5 d after cell infusion. Strikingly, antigen-
dependent induction of Foxp3 expression was efficient in mice
that received thymocytes but barely detectable in animal recipi-
ents of LN cells (Fig. 3E). These results indicated that neither
intrathymic preselection nor specific repertoire features sufficed
to explain the increased susceptibility of thymocytes to differen-
tiate into Treg. From this set of experiments, we conclude that
cell-intrinsic properties account for the differential susceptibility
of thymocytes and LN cells to acquire Foxp3 expression.
Recent Thymic Emigrants Are the Precursors of Tregs That Differentiate
in Conditions of Lymphopenia. The results above show that thy-
mocytes are selectively prone to undergo de novo differentiation
into Treg after exposed to the periphery. We next tested whether
naturally exported thymocytes (i.e., RTEs) share similar features
(Fig. 4). CD4+SP cells naturally exit the thymus before full
maturation and complete their differentiation in the periphery
(25). Consistent with their intermediate maturation stage, recent
thymic emigrants (RTEs) can be identified through their in-
termediate levels of expression for CD24 and Qa-2 (25) com-
pared with thymocytes and peripheral mature cells (Fig. S4A).
On transfer into TCRβ−/− mice, recent thymic emigrants, iso-
lated as Foxp3− Qa-2lo cells from LN preparation, gave rise to
similar frequencies and numbers of Foxp3+ cells as thymocytes.
In contrast, peripheral mature cells purged of RTEs (Foxp3−
Qa-2hi) showed only a residual capacity to differentiate into
Treg, which was indicated by less than 1% Foxp3+ cells in the
recovered CD4 T lymphocytes (Fig. 4A).
To confirm that most or all Treg progenitors in the periphery
are encompassed in the RTE subset, we tested LN cells prepared
from mice naturally purged of RTE by prior thymectomy (Fig.
4B and Fig. S4B). Donor mice were thymectomized (TxT) or as
a control, submitted to the surgery procedure except for thymus
removal (sham) and left to rest for at least 2 mo. At this time
point, preexisting RTEs in TxT mice had incorporated the ma-
ture T-cell pool as indicated by the absence of Qa2lo cells in the
peripheral organs In support of our hypotheses, de novo differ-
entiated Foxp3+ cells were not at all or only barely detectable in
mice that had received cells from thymectomized donors,
whereas as expected, cells from sham-operated donors converted
into Treg at low but readily detectable levels. Taken together,
these results confirm that maturation stage defines T-cell sus-
ceptibility to acquire Foxp3 expression and show that RTEs are
the main, if not the exclusive, precursors of Treg differentiating
in the periphery under conditions of lymphopenia.
Peripheral T-Cell Maturation Associates with Altered Sensitivity to
Signals Modulating Treg Differentiation in Vitro and in Vivo. Our
results above indicating that cell-intrinsic features restrict Foxp3
induction in mature cells suggested that peripheral maturation
alters T-cell sensitivity to signals either favoring or inhibiting Foxp3
induction. To test these possibilities, we first assessed the sensitivity
of each T-cell subset to bona fide inducers of Foxp3 in vitro, namely
TCR triggering and TGF-β. Monitoring the response of anti-minor
histocompatibility Y antigen (HY) TCR transgenic (tg) cells to
broad-range titration of their nominal peptide (Fig. 5A) confirmed
that the lower the TCR triggering, the larger the frequency of cells
acquiring Foxp3 expression (26, 27).More importantly, the slope of
the dose–response obtained in thymocyte cultures was much
steeper than the slope in peripheral cells, indicating differential
Fig. 3. Enhanced susceptibility of thymocytes to differentiate into Treg in
vivo is a cell-intrinsic property. Adoptive transfers as in Fig.1 with the fol-
lowing alterations. (A) Recipients were athymic nude Foxn1−/− mice. (B)
Donor cells were from LN purged (GFP−RBhi) or not (GFP−) of activated cells
by selecting CD45RBhigh cells (Fig. S3). (C) LN and thymocyte donor cells were
isolated from Thy1.1 and Thy1.2 Foxp3-gfp mice, respectively, and coinjected
at a 1:1 ratio (Left). Analyses were gated on Thy1.1+ (LN) or Thy1.2+ (THY).
(D) Donor cells were either total (GFP−) or purged of potential precommitted
CD25+ cells (GFP−25−) as illustrated in Fig. S3. (E) Donor cells were isolated
from OTII Foxp3-gfp Rag2−/− animals. TCRβ−/−-recipient mice received 0.1 mg
OVA or PBS i.v. the day before and 5 d after adoptive transfer. Analysis was
performed at day 8. Shown is one of at least two experiments for each
condition. *P < 0.05; **P < 0.01.
6496 | www.pnas.org/cgi/doi/10.1073/pnas.1221955110 Paiva et al.
sensitivity to TCR triggering. Decreased sensitivity of mature cells
to TGF-β was evidenced in three independent in vitro assays. First,
it was evidenced by monitoring cultures of monoclonal or poly-
clonal cells stimulated by the nominal peptide or anti-CD3 Ab in
the presence of varying concentrations of exogenous TGF-β (Fig. 5
B andC). Second, it was evidenced by performing titration of TGF-
β–neutralizing antibodies to reach suboptimal concentrations of
TGF-β (Fig. 5D). Third, it was evidenced by testing cells prepared
from donor mice expressing a dominant negative form of the TGF-
β receptor II (28) that are partially impaired in signaling (Fig. 5E).
Finally, analysis of recipient mice that received thymocytes or LN
cells from the same dnTGF-βRII donors confirmed that TGF-β
signaling promotes Treg induction during lymphopenia (Fig. 5F).
We next assessed the sensitivity of each T-cell subset to in-
flammatory signals known to inhibit Foxp3 induction (29, 30)
(Fig. 6). The acquisition of Foxp3 expression by LN cells but not
thymocytes was reduced in cultures containing preactivated in-
stead of immature antigen-presenting cells (APCs) (Fig. 6 A–D).
This effect was detectable in cultures supplemented or not with
IL-2 (Fig. 6 A and B vs. Fig. 6C). In the latter conditions, mature
cells converted better than thymocytes when stimulated with
immature dendritic cells (iDC), a result likely related to the re-
duced ability of immature T cells to produce IL-2 on TCR en-
gagement (25). In agreement with this proposition, activation of
APCs enhanced thymocytes conversion, presumably by in-
creasing their IL-2 production. However, mature T-cell conver-
sion was inhibited by APC activation. This inhibitory effect was
mediated by IL-6, because it was lost in cultures seeded with
APC from IL-6−/− mutants (Fig. 6D). We further tested and
confirmed that Qa-2lo RTEs, similarly to newly formed thymo-
cytes (5), are less sensitive than mature T cells to IL-6 in an
APC-free system, where IL-6 could be titrated (Fig. 6E). In
agreement with these results, the frequency of peripheral cells
that converted on adoptive transfer into TCRβ−/−IL-6−/− double
mutant mice was increased compared with IL-6–sufficient re-
cipients. However, irrespective of IL-6 deficiency, thymocytes
performed better than LN cells at acquiring Foxp3 expression in
vivo (Fig. 6F and Fig. S5 A and B), confirming that other features
limit mature cell conversion. Among other cytokines that could
affect Foxp3 induction, only IL-4 and to a lower extent, TNFα
showed a noticeable inhibitory effect that affected mature more
than immature T cells, possibly explained by the lower level of
surface receptor expression (Fig. 6E and Fig. S5 C and D). We
next tested the effect of retinoic acid, known to enhance Treg
differentiation, both in vitro and in vivo (31) and revealed that it
did not affect thymocytes (Fig. 6G). From this set of experi-
ments, we conclude that T-cell maturation associates with several
features impairing their susceptibility to acquire Foxp3 expression.
Human RTEs Are More Susceptible than Mature Cells to Differentiate
into Treg. We next tested whether our findings, indicating that
peripheral maturation limits T-cell susceptibility to differentiate
into Treg, can be extended to humans. Human naïve CD4+
CD25−CD127hi lymphocytes are devoid of Foxp3-expressing cells
and can acquire Foxp3 expression and suppressive functions
in vitro on stimulation with anti-CD3 in the presence of TGF-β
Fig. 4. Recent thymic emigrants are the main precursors of
peripherally differentiated Tregs. Adoptive transfers as in
Fig.1 with the following alterations. (A) Donor LN cells were
either purged or enriched for Qa-2lo RTEs (Left) before adop-
tive transfer (Right). (B) Donor mice were TxT or sham 2–3 mo
before LN CD4+Foxp3− cells were purified (Left) and trans-
ferred to TCRβ−/−-recipient mice (Right). *P < 0.05; **P < 0.01.
Fig. 5. Enhanced sensitivity of immature T cells to TGF-
β–dependent induction of Foxp3 expression in vitro. (A and B)
CD8− CD4+ thymocytes and LN cells isolated from female
Rag− /−Foxp3-gfp anti-HY TCR tg mice were set in cultures
containing T cell-depleted splenocytes (spAPCs), IL-2, and
TGF-β at 0.2 ng/mL (A) or as indicated (B) and the nominal
peptide at the indicated concentration (nM). (C ) Polyclonal
CD8−CD4+Foxp3− cells stimulated as in B except for anti-
CD3Ab (μg/mL) instead of peptide. (D) Polyclonal LN cells
fractionated as mature resident cells (Qa-2hi) or RTEs (Qa-2lo)
were cultured in the presence of spAPCs, 0.1 μg/mL anti-CD3 Ab,
IL-2, and the indicated concentration (μg/mL) of neutralizing
anti–TGF-β Abs. Results are expressed as percentage of re-
sponse in the absence of neutralizing Abs. (E and F) Peripheral
(LN) and thymic (THY) CD8−CD4+Foxp3− cells were purified
from Foxp3-gfp TGF-βRIIdn tg double mutant mice and cul-
tured (E) as in C or transferred (F) to TCRβ−/− mice as in Fig.1.
*P < 0.05.









(Fig. 7 and Fig. S6). Among these cells, FOXP3brightCD25high
are bona fide Treg (32). Human RTEs are enriched in the
CD31+ cell subset (33) that represents 50–80% of the naïve cells
in peripheral blood of healthy donors (Fig. S6), a variation pre-
viously associated with age and thymic involution (34). We tested
CD4SP CD25−CD127hi thymocytes isolated from patients un-
dergoing heart surgery in parallel with CD31+ and CD31− naïve
cells both isolated from blood of the same healthy donor for their
capacity to acquire a Treg phenotype in vitro (Fig. 7A). A pairwise
comparison revealed that seven of eight donors analyzed showed
more efficient conversion when CD31+ instead of CD31− cells
were tested (Fig. 7B). Noticeably, the percentage of CD31+ in total
naïve cells presorting correlated with the increased efficiency of this
cell subset to acquire Foxp3 expression, a result that we interpret as
reflecting proportional enrichment in RTEs (Fig. 7C). Finally,
analysis of thymocytes compared with peripheral blood cells also
supported the notion that, in human as in mice, peripheral matu-
ration affects T-cell susceptibility to differentiate into Treg.
Discussion
There is increasing hope that inducing de novo differentiation of
Treg would offer a potential therapeutic solution for autoim-
munity and allergy. However, preventing de novo Treg de-
velopment is needed to improve tumor immunotherapies and
vaccine efficacy. Our findings that extrathymic maturation of CD4
T cells limits their capacity to differentiate into Tregs in mice and
humans have several consequences for our understanding of
immune regulation and should be relevant for the rational de-
velopment of therapeutic approaches.
We tested the hypothesis that T-cell maturation stage limits
peripheral Treg differentiation by monitoring induction of Foxp3
expression under lymphopenic conditions. The lymphopenia-
induced Foxp3 expression assay presents the advantage of testing
polyclonal cells developed in a WT host for their spontaneous
differentiation into Tregs. It also mimics the severe peripheral
lymphopenia that takes place in various pathophysiological sit-
uations, such as on infection or in clinical settings (for instance,
on high-dose corticosteroid administration). Moreover, the
physiological relevance of pTreg generated during lymphopenia
has been previously shown in a model of colitis (8). In addition,
induction of Treg on lymphopenia is readily detectable, which
allows for reliable quantitative measurements.
Our findings indicating that cell maturation restricts T-lympho-
cyte susceptibility to acquire a Treg phenotype are consistent with
other studies concerned with thymic Treg differentiation. Hence,
thymocytes from newborns were more readily differentiated into
Tregs than thymocytes from adults (35). Moreover, thymic APCs
were shown to be more potent at sustaining thymocyte than pe-
ripheral naïve cell conversion (36). Although these studies did not
provide a molecular mechanism to these differences, our present
work indicates that they relate to specific sensitivity to factors pro-
moting (TCR andTGF-β) and inhibiting (IL-6) Treg differentiation.
Others have already argued how unlikely it is that a single molecule
or pathway would explain the functional differences between im-
mature and mature T cells (37). Importantly, our findings are also
compatible with the notion that mucosa, a microenvironment rich in
TGF-β and retinoic acid where inflammation is maintained at check,
efficiently supports the differentiation of Tregs (31, 38). The concept
brought about by our analysis is that systemic peripheral conversion
(i.e., in situations of limited retinoic acid and TGF-β and/or in in-
flammatory context) is restricted to RTEs.
Fig. 6. Enhanced sensitivity of mature T cells to modulators
of Foxp3 induction. CD8−CD4+Foxp3− cells purified as in Fig. 1
were set in cultures containing anti-CD3 Ab at 0.1 μg/mL and
supplemented with varying APCs and/or compounds. (A and
B) APCs were either immature (A) or activated (B) bone mar-
row-derived dendritic cells (DCs), and media were supple-
mented with IL-2 and either neutralizing anti–TGF-β Ab or
TGF-β. (C) The same as A and B, except that media did not
contain IL-2 and TGF-β was fixed at 0.2 ng/mL. (D) The same as
A and B, except that spAPCs were from either WT or IL-6−/−
mice and media contained IL-2 and TGF-β (0.2 ng/mL). (E) LN
cells were fractionated as mature resident cells (Qa-2hi) and
RTEs (Qa-2lo), plates were coated with anti-CD3 Abs, and
media were supplemented with IL-2 as well as the indicated
cytokines. Shown is normalized frequency (%) of Foxp3+ cells
in TGF-β and IL-6 or IL-4 conditions relative to TGF-β alone. (F)
Adoptive transfers as in Fig. 1, except that recipient mice were
TCRβ−/− IL-6−/− double mutants. (G) APCs were naïve spAPCs,
and media contained IL-2, 0.2 ng/mL TGF-β, and the indicated
concentration of retinoic acid (RA). *P < 0.05; **P < 0.01.
Fig. 7. Preferential differentiation of human thymocytes and RTEs into Treg
ex vivo. Human thymocytes and peripheral blood mononuclear cells sorted
as CD8−CD4+CD25−CD127hi, and for peripheral blood mononuclear cells,
according to CD31 expression, they were cultured for 5 d in media containing
IL-2 alone or supplemented with plate-bound anti-CD3 mAbs, soluble anti-
CD28 mAbs, and TGF-β (TCR+TGF). (A) FACS analysis within live lymphocytes
after culture. (B) Frequency of induced FOXP3brightCD25high. Each pair of
CD31−/CD31+ represents one blood donor (paired t test). Thymocytes were
from another cohort (n = 14). (C) Correlation between the frequencies of
CD31+ cells among naïve cells before sorting and the fold increase in iTreg
frequency comparing CD31+ with CD31− cell cultures. Colored symbols
highlight the highest and lowest responders in B and C. Spearman coefficient
test: r and P were 0.5238 and 0.0983, respectively. *P < 0.05; **P < 0.01.
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Earlier works supported directly or indirectly the notion that
RTEs preferentially mediate peripheral dominant tolerance [for
instance, to mismatched graft (39) and myelin basic protein on
oral administration in a preventive setting for encephalomyelitis
(40)]. In contrast, the more recent literature on Foxp3+ cells
seems to assume that any naïve cell can be a precursor of pTreg
provided that they express the proper TCR specificity and are
presented antigen in the right context. Intriguingly, only a small
fraction of cells has been successfully induced to expressed
Foxp3 in vivo in various assays, including in monoclonal TCR
transgenic mice infused for long periods with the nominal pep-
tide (6). Our present finding that RTEs, a limited cell subset in
the periphery, are the preferential or exclusive precursors of
pTreg explains this limitation. In turn, a limited pool of pTreg
precursors should guarantee efficient immunity again pathogens.
Our findings also provide a rationale to older notions linking
ontogeny and immune tolerance. Thus, as shown already in the
work by Billingham et al. (41) in 1953, immune tolerance prevails
early in life. Moreover, after the development of a functional
thymus, the peripheral pool of T cells is first formed by output
from the thymus with little peripheral expansion (42). Hence,
during perinatal development, peripheral T cells are RTEs, and
as we show here, they are prone to differentiate into Treg, en-
suring robust tolerance.
Finally, our work reveals a third mechanism by which the adult
thymus contributes to peripheral tolerance. As first evidenced in
the 1990s, selection of natural Treg takes place in the thymus on
TCR triggering by self-antigens. As shown later, these self-anti-
gens include the products of tissue-specific genes expressed by
thymic epithelial cells (2). Moreover, recirculation of peripheral
antigens to the thymus also shapes Treg repertoire (5). Lastly, as
we show here, recently differentiated T cells have a limited devel-
opmental time window before full maturation in the periphery to
readily acquire Foxp3, placing RTEs as the precursors of pTregs.
Because the thymus involutes with age and is depleted in the course
of infections and on administration of various drugs, these prop-
erties call for specific attention to thymic activities in the rational
development of therapies to enhance or prevent immune tolerance.
Materials and Methods
SI Materials and Methods contains detailed description of (i) human donors
and samples preparation, (ii ) animals and methods of thymectomy, cell
adoptive transfer, and antigen administration, and (iii) reagents and methods
for cell purification, in vitro assays, FACS, and statistical analysis. Table S1
details antibodies used for FACS analysis and cell culture. Human and animal
studies were approved by the Ethical Board of the Faculty of Medicine,
Lisbon, the Institutional Ethical Committee, and the Portuguese Veterinary
General Division.
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